- Home
- ALXO vs MHUA Comparison
ALXO vs MHUA Comparison
Compare ALXO & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- MHUA
- Stock Information
- Founded
- ALXO 2015
- MHUA 1990
- Country
- ALXO United States
- MHUA China
- Employees
- ALXO N/A
- MHUA N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- MHUA Medical Specialities
- Sector
- ALXO Health Care
- MHUA Health Care
- Exchange
- ALXO Nasdaq
- MHUA Nasdaq
- Market Cap
- ALXO 24.0M
- MHUA 19.6M
- IPO Year
- ALXO 2020
- MHUA 2022
- Fundamental
- Price
- ALXO $0.61
- MHUA $0.39
- Analyst Decision
- ALXO Strong Buy
- MHUA
- Analyst Count
- ALXO 6
- MHUA 0
- Target Price
- ALXO $3.30
- MHUA N/A
- AVG Volume (30 Days)
- ALXO 500.5K
- MHUA 166.4K
- Earning Date
- ALXO 08-07-2025
- MHUA 09-19-2025
- Dividend Yield
- ALXO N/A
- MHUA N/A
- EPS Growth
- ALXO N/A
- MHUA N/A
- EPS
- ALXO N/A
- MHUA 0.40
- Revenue
- ALXO N/A
- MHUA $96,909,642.00
- Revenue This Year
- ALXO N/A
- MHUA N/A
- Revenue Next Year
- ALXO N/A
- MHUA N/A
- P/E Ratio
- ALXO N/A
- MHUA $0.99
- Revenue Growth
- ALXO N/A
- MHUA N/A
- 52 Week Low
- ALXO $0.40
- MHUA $0.25
- 52 Week High
- ALXO $6.08
- MHUA $1.47
- Technical
- Relative Strength Index (RSI)
- ALXO 61.99
- MHUA 46.45
- Support Level
- ALXO $0.44
- MHUA $0.38
- Resistance Level
- ALXO $0.64
- MHUA $0.41
- Average True Range (ATR)
- ALXO 0.04
- MHUA 0.03
- MACD
- ALXO 0.01
- MHUA -0.01
- Stochastic Oscillator
- ALXO 72.40
- MHUA 21.60
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.